Read more

March 28, 2024
2 min read
Save

NIH picks Kathleen M. Neuzil, MD, MPH, to lead Fogarty International Center

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Neuzil will be the first woman to lead the NIH’s Fogarty International Center.
  • She has been director of the University of Maryland’s Center for Vaccine Development and Global Health since 2015.

The NIH has chosen vaccine researcher Kathleen M. Neuzil, MD, MPH, to be the new director of the Fogarty International Center.

Neuzil, who will be the first woman to be permanent director of the center, will also be the NIH’s associate director for international research. She is expected to step down as director of the University of Maryland’s Center for Vaccine Development and Global Health, which she has led since 2015, and join the NIH in May, the university said.

IDN0324Neuzil_Graphic_02_WEB
The NIH has chosen vaccine researcher Kathleen M. Neuzil, MD, MPH, to be the new director of the Fogarty International Center. Image: Adobe Stock

“Dr. Neuzil has decades of experience in global health, specifically in vaccinology. Her impressive research portfolio includes clinical and epidemiological studies into dozens of infectious diseases,” NIH Director Monica M. Bertagnolli, MD, said in a press release. “Combined with her many years as a vaccine policy advisor to the CDC and WHO, and her experience establishing new partnerships and directing diverse organizational teams, she is very well-suited to lead [Fogarty].”

Fogarty is at the center of the NIH’s efforts in international health affairs. The center’s $86 million budget is distributed mostly through a series of grant programs to a variety of research and training partners. More than 8,000 scientists from 132 countries have been trained through Fogarty programs since 1989, according to the center.

Neuzil, who replaces acting director Peter H. Kilmarx, MD, has published more than 330 scientific articles on vaccines, vaccine uptake and infectious diseases, including influenza, typhoid and COVID-19.

Neuzil, who is also a professor of vaccinology and chief of the division of geographic medicine at the University of Maryland School of Medicine, was also named the university’s researcher of the year in 2023, at least partially for her work leading several COVID-19 vaccine trials.

References: